Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,776 across all filing types
Latest filing 2023-01-18 Governance Information
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
金宇生物技术股份有限公司独立董事工作制度（2023年1月修订）
Governance Information Classification · 95% confidence The document is a detailed internal governance policy specifically about the independent directors' working system at a company. It references laws, regulations, and company bylaws related to corporate governance and independent directors' duties, qualifications, nomination, and rights. There is no financial data, no mention of financial results, no shareholder meeting materials, no voting results, no legal proceedings, no capital changes, no earnings announcements, and no regulatory filings or certifications. The content is focused on governance practices and internal rules regarding board structure and director responsibilities. Therefore, the document fits best under the category of Governance Information (CGR). The document length is 3950 characters, which is sufficient for a detailed governance report rather than a brief announcement or notice.
2023-01-18 Chinese
金宇生物技术股份有限公司章程（2023年1月修订）
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of 金宇生物技术股份有限公司, revised in January 2023. It contains detailed provisions on company organization, shareholder rights, board structure, management, financial accounting, profit distribution, auditing, shareholder meetings, voting procedures, and other governance matters. It is a comprehensive governance document outlining internal rules and procedures for the company and its shareholders. There is no indication that this is an announcement, a financial report, or a meeting transcript. The content matches the definition of Governance Information (CGR), which covers the company's internal rules, board structure, and governance practices.
2023-01-18 Chinese
金宇生物技术股份有限公司第十一届董事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at a board of directors meeting, including changes to the board structure, appointment of an independent director, amendments to governance documents, and appointment of the board secretary. It includes voting results and references to further announcements on the stock exchange website. The content focuses on board and management changes and governance matters rather than financial results or reports. The document length is short (1629 characters) and it is a formal announcement of board decisions, not a full report or detailed financial disclosure. Therefore, it fits best under 'Board/Management Information' (MANG).
2023-01-18 Chinese
金宇生物技术股份有限公司独立董事候选人声明-耿明
Board/Management Information Classification · 95% confidence The document is a declaration statement by an independent director candidate of a company, detailing qualifications, independence criteria, and compliance with regulatory requirements. It is a formal statement related to board membership candidacy, not a financial report, audit, or earnings release. It does not announce voting results or changes in management but is a candidate's declaration. This type of document fits best under Board/Management Information (MANG) as it pertains to board member nomination and qualifications.
2023-01-18 Chinese
金宇生物技术股份有限公司关于增选独立董事的公告
Board/Management Information Classification · 95% confidence The document is an announcement from a company about the election of an additional independent director to its board. It details the nomination, qualifications, and compliance with relevant laws and regulations. There is no financial data, earnings information, or report attached. The content focuses on board composition changes and governance structure. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or regulatory filing. Hence, the classification is MANG with high confidence.
2023-01-18 Chinese
金宇生物技术股份有限公司独立董事关于第十一届董事会第四次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from independent directors regarding the nomination of a new independent director and the appointment of a board secretary. It references compliance with company law, stock exchange rules, and company bylaws. There is no financial data, earnings information, or report publication mentioned. The content focuses on board/management changes and governance matters. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or a certification, so it is not RPA or RNS.
2023-01-18 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.